{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:59:06Z","timestamp":1780451946578,"version":"3.54.1"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00587","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T05:07:54Z","timestamp":1589346474000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates"],"prefix":"10.3389","volume":"11","author":[{"given":"Anne","family":"Smits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Van Cruchten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.freeradbiomed.2019.02.025","article-title":"Neuroprotective strategies following perinatal hypoxia-ischemia: Taking aim at NOS","volume":"142","author":"Albrecht","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/157488407779422294","article-title":"Determinants of drug metabolism in early neonatal life","volume":"2","author":"Allegaert","year":"2007","journal-title":"Curr. Clin. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/FTD.0b013e3181a8cc0a","article-title":"In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age","volume":"31","author":"Allegaert","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"B4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/archdischild-2013-303688","article-title":"Paracetamol to induce ductus arteriosus closure: is it valid","volume":"98","author":"Allegaert","year":"2013","journal-title":"Arch. Dis. Child"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.2174\/1381612823666170926121124","article-title":"Developmental Pharmacokinetics in Neonates: Maturational Changes and Beyond","volume":"23","author":"Allegaert","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.ejps.2017.05.023","article-title":"Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology","author":"Allegaert","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.2174\/138161282441190320125910","article-title":"Perspectives in Neonatal Pharmacology: Drug Discovery, Knowledge Integration and Structured Prioritization","volume":"24","author":"Allegaert","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"B8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000499742","article-title":"Phenobarbital Increases Midazolam Clearance in Neonates Treated with Hypothermia: Do We Really Need to Know","volume":"116","author":"Allegaert","year":"2019","journal-title":"Neonatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bja.2018.01.034","article-title":"Plasma concentrations of alpha-1-acid glycoprotein in preterm and term newborns: influence of mode of delivery and implications for plasma protein binding of local anaesthetics","volume":"121","author":"Anell-Olofsson","year":"2018","journal-title":"Br. J. Anaesth"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2431-8-17","article-title":"The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial","volume":"8","author":"Azzopardi","year":"2008","journal-title":"BMC Pediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","article-title":"Moderate hypothermia to treat perinatal asphyxial encephalopathy","volume":"361","author":"Azzopardi","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa1315788","article-title":"Effects of hypothermia for perinatal asphyxia on childhood outcomes","volume":"371","author":"Azzopardi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12565","article-title":"Melatonin pharmacokinetics and dose extrapolation after enteral infusion in neonates subjected to hypothermia","volume":"66","author":"Balduini","year":"2019","journal-title":"J. Pineal Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11096-012-9725-0","article-title":"Pharmacokinetics of midazolam in resuscitated patients treated with moderate hypothermia","volume":"35","author":"Bastiaans","year":"2013","journal-title":"Int. J. Clin. Pharm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/adc.57.2.141","article-title":"Gastrointestinal permeability changes in the preterm neonate","volume":"57","author":"Beach","year":"1982","journal-title":"Arch. Dis. Child"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/bcp.12883","article-title":"Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia","volume":"81","author":"Bijleveld","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/cpt.748","article-title":"Population Pharmacokinetics of Amoxicillin in Term Neonates Undergoing Moderate Hypothermia","volume":"103","author":"Bijleveld","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.vascn.2010.05.009","article-title":"The utility of the minipig as an animal model in regulatory toxicology","volume":"62","author":"Bode","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1152\/ajplegacy.1945.145.2.190","article-title":"Age, sex, carbohydrate, adrenal cortex and other factors in anoxia","volume":"145","author":"Britton","year":"1945","journal-title":"Am. J. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1460-9592.2011.03771.x","article-title":"Pharmacokinetic profiles of epidural bupivacaine and ropivacaine following single-shot and continuous epidural use in young infants","volume":"22","author":"Calder","year":"2012","journal-title":"Paediatr. Anaesth"},{"key":"B21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/mus.880090510","article-title":"Distribution of capillaries in normal and diseased human skeletal muscle","volume":"9","author":"Carry","year":"1986","journal-title":"Muscle Nerve"},{"key":"B22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.steroids.2003.10.004","article-title":"Within-person variability of urinary 6beta-hydroxycortisol to urinaryl ratios in Caucasian women","volume":"69","author":"Chen","year":"2004","journal-title":"Steroids"},{"key":"B23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2125.2006.02628.x","article-title":"Poor correlation between 6beta-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity","volume":"62","author":"Chen","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3791\/3166","article-title":"A swine model of neonatal asphyxia","volume":"56","author":"Cheung","year":"2011","journal-title":"J. Vis. Exp."},{"key":"B25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/jcpt.12711","article-title":"Effect of hypothermia treatment on gentamicin pharmacokinetics in neonates with hypoxic-ischaemic encephalopathy: A systematic review and meta-analysis","volume":"43","author":"Choi","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/phar.1916","article-title":"Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia","volume":"37","author":"Cies","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1177\/0192623315617562","article-title":"The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey","volume":"44","author":"Colleton","year":"2016","journal-title":"Toxicol. Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e01282","DOI":"10.1128\/AAC.01282-17","article-title":"Amikacin Pharmacokinetics To Optimize Dosing in Neonates with Perinatal Asphyxia Treated with Hypothermia","volume":"61","author":"Cristea","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e00853","DOI":"10.1128\/AAC.00853-19","article-title":"Larger Dose Reductions of Vancomycin Required in Neonates with Patent Ductus Arteriosus Receiving Indomethacin versus Ibuprofen","volume":"63","author":"Cristea","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00431-018-3245-4","article-title":"Changes in bilirubin in infants with hypoxic-ischemic encephalopathy","volume":"177","author":"Dani","year":"2018","journal-title":"Eur. J. Pediatr."},{"key":"B31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-981-10-5336-8_12","article-title":"Antibiotic dosing in pediatric critically ill patients","volume-title":"Antibiotic Pharmacokinetic\/Pharmacodynamic considerations in the critically ill.","author":"De Cock","year":"2018"},{"key":"B32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","article-title":"Cytochrome P450 3A: ontogeny and drug disposition","volume":"37","author":"De Wildt","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2125.2010.03773.x","article-title":"4beta-Hydroxycholesterol, an endogenous marker of CYP3A4\/5 activity in humans","volume":"71","author":"Diczfalusy","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B34","first-page":"157","article-title":"Study of the Urinary Ratio of 6 beta-Hydroxycortisol\/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases","volume":"1","author":"Eldesoky","year":"2007","journal-title":"Biomark Insights"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/CCM.0b013e31823779f9","article-title":"Mild hypothermia decreases fentanyl and midazolam steady-state clearance in a rat model of cardiac arrest","volume":"40","author":"Empey","year":"2012","journal-title":"Crit. Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/aas.12318","article-title":"Pharmacokinetics of dexmedetomidine combined with therapeutic hypothermia in a piglet asphyxia model","volume":"58","author":"Ezzati","year":"2014","journal-title":"Acta Anaesthesiol. Scand."},{"key":"B37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000499330","article-title":"Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia","volume":"116","author":"Favie","year":"2019","journal-title":"Neonatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1152\/ajplegacy.1941.134.2.281","article-title":"Tolerance of the newborn to anoxia","volume":"134","author":"Fazekas","year":"1941","journal-title":"Am. J. Physiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1111\/j.1528-1167.2009.02302.x","article-title":"Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy","volume":"50","author":"Filippi","year":"2009","journal-title":"Epilepsia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1213\/01.ANE.0000146517.17910.54","article-title":"The effect of mild hypothermia on plasma fentanyl concentration and biotransformation in juvenile pigs","volume":"100","author":"Fritz","year":"2005","journal-title":"Anesth. Analg."},{"key":"B41","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/phar.1263","article-title":"Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia","volume":"33","author":"Frymoyer","year":"2013","journal-title":"Pharmacotherapy"},{"key":"B42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/jcph.775","article-title":"Decreased Morphine Clearance in Neonates With Hypoxic Ischemic Encephalopathy Receiving Hypothermia","volume":"57","author":"Frymoyer","year":"2017","journal-title":"J. Clin. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00228-003-0690-3","article-title":"Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals","volume":"59","author":"Galteau","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/14767058.2011.607617","article-title":"Brain cooling and eligible newborns: should we extend the indications","volume":"24","author":"Gancia","year":"2011","journal-title":"J. Mater. Fetal. Neonatal. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/tpj.2010.16","article-title":"Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians","volume":"11","author":"Gebeyehu","year":"2011","journal-title":"Pharmacogenom. J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/jac\/dky128","article-title":"Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies","volume":"73","author":"Germovsek","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/ajplegacy.1944.140.5.609","article-title":"The Rate of decline in resistance to anoxia of rabbits, dogs and guinea pigs from the onset of viability to adult life","volume":"1140","author":"Glass","year":"1944","journal-title":"Am. J. Physio."},{"key":"B48","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/cpt.1472","article-title":"Use of 4beta-Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes","volume":"106","author":"Gravel","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1542\/peds.2008-1955","article-title":"Blood gas values during hypothermia in asphyxiated term neonates","volume":"123","author":"Groenendaal","year":"2009","journal-title":"Pediatrics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.clp.2008.07.012","article-title":"Brain cooling for preterm infants","volume":"35","author":"Gunn","year":"2008","journal-title":"Clin. Perinatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1542\/peds.2008-3211","article-title":"Mild controlled hypothermia in preterm neonates with advanced necrotizing enterocolitis","volume":"125","author":"Hall","year":"2010","journal-title":"Pediatrics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.earlhumdev.2018.08.003","article-title":"Outcomes of preterm infants treated with hypothermia for hypoxic-ischemic encephalopathy","volume":"125","author":"Herrera","year":"2018","journal-title":"Early Hum. Dev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1124\/dmd.109.031377","article-title":"Mild hypothermia alters midazolam pharmacokinetics in normal healthy volunteers","volume":"38","author":"Hostler","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"B54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41390-019-0387-7","article-title":"Understanding the pathobiology in patent ductus arteriosus in prematurity-beyond prostaglandins and oxygen","volume":"86","author":"Hundscheid","year":"2019","journal-title":"Pediatr. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40262-013-0041-1","article-title":"Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations","volume":"52","author":"Ince","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003311.pub3","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy","volume":"1","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/sj.clpt.6100327","article-title":"Development of CYP2D6 and CYP3A4 in the first year of life","volume":"83","author":"Johnson","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/bcp.12425","article-title":"Validation of 4beta-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects","volume":"78","author":"Kasichayanula","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/907461","article-title":"Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development","volume":"2011","author":"Khalil","year":"2011","journal-title":"J. BioMed. Biotechnol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/2168479018774533","article-title":"Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols","volume":"53","author":"Khan","year":"2019","journal-title":"Ther. Innov. Regul. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0039-128X(77)80020-2","article-title":"Radioimmunoassay of 6beta-hydroxycortisol in human plasma and urine","volume":"30","author":"Kishida","year":"1977","journal-title":"Steroids"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s40262-018-0648-3","article-title":"Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug-Drug Interactions","volume":"57","author":"Kunze","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/jso.21051","article-title":"Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy","volume":"98","author":"Kusamura","year":"2008","journal-title":"J. Surg. Oncol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00016","article-title":"Understanding the Full Spectrum of Organ Injury Following Intrapartum Asphyxia","volume":"5","author":"Larosa","year":"2017","journal-title":"Front. Pediatr."},{"key":"B66","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1542\/peds.2008-2942","article-title":"Serum gentamicin concentrations in encephalopathic infants are not affected by therapeutic hypothermia","volume":"124","author":"Liu","year":"2009","journal-title":"Pediatrics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1124\/dmd.113.054361","article-title":"Endogenous 4beta-hydroxycholesterol-to-cholesterol ratio is not a validated biomarker for the assessment of CYP3A activity","volume":"41","author":"Ma","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"B68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/03602532.2016.1239630","article-title":"Perspective: 4beta-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A","volume":"49","author":"Mao","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/FTD.0b013e3182834335","article-title":"Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia","volume":"35","author":"Mark","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"B70","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/apa.14944","article-title":"Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule","volume":"109","author":"Marques","year":"2019","journal-title":"Acta Paediatr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clp.2016.04.007","article-title":"Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics","volume":"43","author":"Mcadams","year":"2016","journal-title":"Clin. Perinatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000137349","article-title":"Effect of hypothermia on drug metabolism. In vitro studies with propranolol and verapamil","volume":"20","author":"Mcallister","year":"1980","journal-title":"Pharmacology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.2174\/1381612823666171009143840","article-title":"PBPK in Preterm and Term Neonates: A Review","volume":"23","author":"Michelet","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"B74","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1515\/cclm.1996.34.5.439","article-title":"Age-dependent reference values of urinary porphyrins in children","volume":"34","author":"Minder","year":"1996","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00000542-200308000-00008","article-title":"Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation","volume":"99","author":"Mulla","year":"2003","journal-title":"Anesthesiology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00431-017-2956-2","article-title":"Biomarkers of hepatic injury and function in neonatal hypoxic ischemic encephalopathy and with therapeutic hypothermia","volume":"176","author":"Muniraman","year":"2017","journal-title":"Eur. J. Pediatr."},{"key":"B77","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s002280050390","article-title":"Changes in urinary 6beta-hydroxycortisol\/cortisol ratio after birth in human neonates","volume":"53","author":"Nakamura","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-2125.1999.00857.x","article-title":"Comparison of urinary 6beta-hydroxycortisol\/cortisol ratio between neonates and their mothers","volume":"47","author":"Nakamura","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B79","unstructured":"Therapeutic hypothermia with intracorporeal temperature monitoring for hypoxic perinatal brain injury2010"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/bcp.13538","article-title":"Was 4beta-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity","volume":"84","author":"Neuhoff","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00228-010-0984-1","article-title":"Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4beta-hydroxycholesterol","volume":"67","author":"Nylen","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1071-9091(05)80004-X","article-title":"Animal models of perinatal asphyxia: contributions, contradictions, clinical relevance","volume":"2","author":"Painter","year":"1995","journal-title":"Semin. Pediatr. Neurol."},{"key":"B83","first-page":"398","article-title":"Age related changes in urinary 6-beta hydroxycortisol in normal infants","volume":"33","author":"Patel","year":"1996","journal-title":"Indian Pediatr."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058834","article-title":"Therapeutic hypothermia for neonatal encephalopathy in low- and middle-income countries: a systematic review and meta-analysis","volume":"8","author":"Pauliah","year":"2013","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.2174\/1381612821666150901110929","article-title":"The Impact of Hypothermia on the Pharmacokinetics of Drugs Used in Neonates and Young Infants","volume":"21","author":"Pokorna","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1080\/14767058.2018.1432039","article-title":"Severity of asphyxia is a covariate of phenobarbital clearance in newborns undergoing hypothermia","volume":"32","author":"Pokorna","year":"2019","journal-title":"J. Mater. Fetal. Neonatal. Med."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00360","article-title":"Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge","volume":"7","author":"Raffaeli","year":"2019","journal-title":"Front. Pediatr."},{"key":"B88","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000243873","article-title":"Some animal models for the study of perinatal asphyxia","volume":"62","author":"Raju","year":"1992","journal-title":"Biol. Neonate"},{"key":"B89","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpeds.2016.11.019","article-title":"Safety and Short-Term Outcomes of Therapeutic Hypothermia in Preterm Neonates 34-35 Weeks Gestational Age with Hypoxic-Ischemic Encephalopathy","volume":"183","author":"Rao","year":"2017","journal-title":"J. Pediatr."},{"key":"B90","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","article-title":"Human renal function maturation: a quantitative description using weight and postmenstrual age","volume":"24","author":"Rhodin","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1651-2227.2007.00361.x","article-title":"Changes in laboratory parameters indicating cell necrosis and organ dysfunction in asphyxiated neonates on moderate systemic hypothermia","volume":"96","author":"Roka","year":"2007","journal-title":"Acta Paediatr."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e844","DOI":"10.1542\/peds.2007-1987","article-title":"Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy","volume":"121","author":"Roka","year":"2008","journal-title":"Pediatrics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/bdd.2160","article-title":"The impact of low temperature on fraction unbound for plasma and tissue","volume":"39","author":"Ryu","year":"2018","journal-title":"Biophar. Drug Dispos."},{"key":"B94","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0887-8994(93)90061-G","article-title":"Brain injury and protective effects of hypothermia using triphenyltetrazolium chloride in neonatal rat","volume":"9","author":"Saeed","year":"1993","journal-title":"Pediatr. Neurol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.pedneo.2019.04.003","article-title":"Gastrointestinal hemodynamic changes during therapeutic hypothermia and after rewarming in neonatal hypoxic-Ischemic encephalopathy","volume":"60","author":"Sakhuja","year":"2019","journal-title":"Pediatr. Neonatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000014195","article-title":"Influence of mild hypothermia after hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs","volume":"77","author":"Satas","year":"2000","journal-title":"Biol. Neonate"},{"key":"B97","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/PCC.0b013e31825bbbc2","article-title":"Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia","volume":"14","author":"Shellhaas","year":"2013","journal-title":"Pediatr. Crit. Care Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1208\/s12248-016-9941-y","article-title":"Urinary 6beta-Hydroxycortisol\/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach","volume":"18","author":"Shin","year":"2016","journal-title":"AAPS J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijpharm.2012.03.035","article-title":"Drug disposition and clinical practice in neonates: cross talk between developmental physiology and pharmacology","volume":"452","author":"Smits","year":"2013","journal-title":"Int. J. Pharm."},{"key":"B100","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/17425255.2017.1234606","article-title":"The amikacin research program: a stepwise approach to validate dosing regimens in neonates","volume":"13","author":"Smits","year":"2017","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/17425255.2019.1558205","article-title":"Physiologically based pharmacokinetic (PBPK) modeling and simulation in neonatal drug development: how clinicians can contribute","volume":"15","author":"Smits","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.freeradbiomed.2019.04.028","article-title":"Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia","volume":"142","author":"Solevag","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/bcp.12752","article-title":"Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds","volume":"81","author":"Somani","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1113\/jphysiol.1960.sp006547","article-title":"The survival of young rats in nitrogen","volume":"153","author":"Stafford","year":"1960","journal-title":"J. Physiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpeds.2016.06.078","article-title":"Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial","volume":"177","author":"Steinhorn","year":"2016","journal-title":"J. Pediatr."},{"key":"B106","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1124\/jpet.103.054841","article-title":"Developmental expression of the major human hepatic CYP3A enzymes","volume":"307","author":"Stevens","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-012-0911-5","article-title":"A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation","volume":"30","author":"Suenderhauf","year":"2013","journal-title":"Pharm. Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5863\/1551-6776-16.3.170","article-title":"Neonatal pharmacology: extensive interindividual variability despite limited size","volume":"16","author":"Tayman","year":"2011","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"B109","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1046\/j.1365-2125.2003.01819.x","article-title":"Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya","volume":"56","author":"Thomson","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12098-014-1527-z","article-title":"Pharmacokinetics of gentamicin in newborns with moderate-to-severe hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia","volume":"82","author":"Ting","year":"2015","journal-title":"Indian J. Pediatr."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/j.1552-4604.1995.tb04021.x","article-title":"Can chronic maternal drug therapy alter the nursing infant's hepatic drug metabolizing enzyme pattern","volume":"35","author":"Toddywalla","year":"1995","journal-title":"J. Clin. Pharmacol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/clpt.2009.72","article-title":"Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric","volume":"86","author":"Tomalik-Scharte","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1097\/01.CCM.0000281517.97507.6E","article-title":"Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system","volume":"35","author":"Tortorici","year":"2007","journal-title":"Crit. Care Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s13193-016-0498-0","article-title":"Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy","volume":"7","author":"Valle","year":"2016","journal-title":"Indian J. Surg. Oncol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1002\/jcph.1284","article-title":"Developmental Changes in Pharmacokinetics and Pharmacodynamics","volume":"58","author":"Van Den Anker","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/11319360-000000000-00000","article-title":"Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies","volume":"49","author":"Van Den Broek","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"B117","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s40262-012-0004-y","article-title":"Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach","volume":"51","author":"Van Den Broek","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"B118","doi-asserted-by":"publisher","first-page":"F341","DOI":"10.1136\/archdischild-2012-302678","article-title":"Anticonvulsant treatment of asphyxiated newborns under hypothermia with lidocaine: efficacy, safety and dosing","volume":"98","author":"Van Den Broek","year":"2013","journal-title":"Arch. Dis. Child Fetal. Neonatal. Ed."},{"key":"B119","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/bcpt.12173","article-title":"Ontogeny of CYP3A and P-glycoprotein in the liver and the small intestine of the Gottingen minipig: an immunohistochemical evaluation","volume":"114","author":"Van Peer","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bcpt.12410","article-title":"Age-related Differences in CYP3A Abundance and Activity in the Liver of the Gottingen Minipig","volume":"117","author":"Van Peer","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s11095-017-2101-y","article-title":"In vitro Phase I- and Phase II-Drug Metabolism in The Liver of Juvenile and Adult Gottingen Minipigs","volume":"34","author":"Van Peer","year":"2017","journal-title":"Pharm. Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s002280050162","article-title":"Non invasive in vivo study of the maturation of CYP IIIA in neonates and infants","volume":"51","author":"Vauzelle-Kervroedan","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1055\/s-0033-1358749","article-title":"Disposition of midazolam in asphyxiated neonates receiving therapeutic hypothermia\u2013a pilot study","volume":"225","author":"Welzing","year":"2013","journal-title":"Klin. Padiatr."},{"key":"B124","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1203\/00006450-197405000-00007","article-title":"Coproporphyrin excretion in amniotic fluid and urine from premature infants: a possible maturation defect","volume":"8","author":"Wolkoff","year":"1974","journal-title":"Pediatr. Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both","volume":"377","author":"Woodcock","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/17425255.2018.1461836","article-title":"Pharmacokinetic considerations for pediatric patients receiving analgesia in the intensive care unit; targeting postoperative, ECMO and hypothermia patients","volume":"14","author":"Zeilmaker","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1124\/dmd.114.058602","article-title":"Evaluation of calibration curve-based approaches to predict clinical inducers and noninducers of CYP3A4 with plated human hepatocytes","volume":"42","author":"Zhang","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"B128","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/psp4.12101","article-title":"Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children","volume":"5","author":"Zhou","year":"2016","journal-title":"CPT Pharmacometr. Syst. Pharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/cpt.905","article-title":"Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children","volume":"104","author":"Zhou","year":"2018","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T05:08:00Z","timestamp":1589346480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":129,"alternative-id":["10.3389\/fphar.2020.00587"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00587","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"article-number":"587"}}